Recent studies have shown blood plasma transfusion therapy can reduce the death rate in Covid-19 patients.
Even though the patient has severe symptoms.
The research, published in The American Journal of Pathology, raises hopes for a treatment for coronavirus infection.
Peer reviews have also been conducted on this study.
A study from the Houston Methodist Hospital, USA on 316 patients analyzed the outcome of plasma therapy with a group of patients who did not receive plasma therapy.
The researchers examined the patient’s condition for 28 days.
As a result, blood plasma therapy significantly reduced the mortality rate in Covid-19 patients.
The mortality rate decreased since blood plasma was transfused within three days of the patient being admitted to the hospital.
In addition to reducing mortality, plasma transfusions also reduce complications that arise from Covid-19.
The blood plasma used is blood plasma which contains a high concentration of neutralizing antibodies.
These antibodies come from blood donated by Covid-19 patients who have been declared cured.
Covid-19 patients who have recovered have antibodies that work against the coronavirus in their blood plasma.
This powerful antibody is used in Covid-19 patients by means of blood transfusions.
Blood plasma therapy is a method in medicine that is often used to treat infectious diseases.
